Matches in Nanopublications for { ?s ?p "[In conclusion, we uncovered an ALK-specific regulation of the hypoxia response across different ALK(+) tumor types and propose HIFs as a powerful specific therapeutic target in ALK-rearranged ALCL and NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[In conclusion, we uncovered an ALK-specific regulation of the hypoxia response across different ALK(+) tumor types and propose HIFs as a powerful specific therapeutic target in ALK-rearranged ALCL and NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In conclusion, we uncovered an ALK-specific regulation of the hypoxia response across different ALK(+) tumor types and propose HIFs as a powerful specific therapeutic target in ALK-rearranged ALCL and NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP235592.RAqzKOkamsNIQH51OC4DH3tKT01diq73wAzsu-UdmLWWY130_assertion description "[In conclusion, we uncovered an ALK-specific regulation of the hypoxia response across different ALK(+) tumor types and propose HIFs as a powerful specific therapeutic target in ALK-rearranged ALCL and NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235592.RAqzKOkamsNIQH51OC4DH3tKT01diq73wAzsu-UdmLWWY130_provenance.
- NP1217388.RAtpX3G7mjmD_YlkcarJxfYrncbUuGT1RL_7-bfrf_uPk130_assertion description "[In conclusion, we uncovered an ALK-specific regulation of the hypoxia response across different ALK(+) tumor types and propose HIFs as a powerful specific therapeutic target in ALK-rearranged ALCL and NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217388.RAtpX3G7mjmD_YlkcarJxfYrncbUuGT1RL_7-bfrf_uPk130_provenance.
- NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_assertion description "[In conclusion, we uncovered an ALK-specific regulation of the hypoxia response across different ALK(+) tumor types and propose HIFs as a powerful specific therapeutic target in ALK-rearranged ALCL and NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_provenance.